Search results
Results from the WOW.Com Content Network
The journal publishes both full-length and mini-reviews, original research, meta-analysis, and results from clinical studies. In addition, the journal has published manuscripts focused on ethical and regulatory considerations of gene and cell therapy. As well as important regulatory, manufacturing, and logistical aspects of gene therapy research.
It is unknown how this type of gene therapy affects long-term human development. In the United States, federal funding cannot be used to research germline gene therapy. [17] The ethical challenges in gene therapy for rare childhood diseases underscore the complexity of initiating trials, determining dosage levels, and involving affected families.
The ethical issues concerning gene doping have been present long before its discovery. Although gene doping is relatively new, the concept of genetic enhancement of any kind has always been subject to ethical concerns. Even when used in a therapeutic manner, gene therapy poses many risks due to its unpredictability among other reasons.
Medical genetic ethics is a field in which the ethics of medical genetics is evaluated. Like the other field of medicine, medical genetics also face ethical issues. The availability of direct to consumer (DTC) genetic testing to analyses the genetic variants which predispose the individuals to medical conditions like breast cancer and ovarian cancer [1] demands the review of the guidelines ...
Gene therapy is a medical technology that aims to ... A 2020 issue of the journal Bioethics was devoted to ... Considering the ethical aspect of gene diagnostic and ...
In bioethics, the ethics of cloning concerns the ethical positions on the practice and possibilities of cloning, especially of humans. While many of these views are religious in origin, some of the questions raised are faced by secular perspectives as well. Perspectives on human cloning are theoretical, as human therapeutic and reproductive ...
As a way to introduce new genetic information to change a person's phenotype, a gene therapy for color blindness is open to the same ethical questions and criticisms as gene therapy in general. These include issues around the governance of the therapy, whether treatment should be available only to those who can afford it, and whether the ...
The framework lacks the requisite international treaties for enforcement. At the first International Summit on Human Gene Editing in December 2015 researchers issued the first international guidelines. [16] These guidelines allowed pre-clinical research into gene editing in human cells as long as the embryos were not used to implant pregnancy.